FI70415C - Foerfarande foer framstaellning av terapeutiskt anvaendbara petider - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara petider Download PDF

Info

Publication number
FI70415C
FI70415C FI783589A FI783589A FI70415C FI 70415 C FI70415 C FI 70415C FI 783589 A FI783589 A FI 783589A FI 783589 A FI783589 A FI 783589A FI 70415 C FI70415 C FI 70415C
Authority
FI
Finland
Prior art keywords
formula
peptide
tyr
gly
met
Prior art date
Application number
FI783589A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI70415B (fi
FI783589A (fi
Inventor
Samuel Wilkinson
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI783589A publication Critical patent/FI783589A/fi
Publication of FI70415B publication Critical patent/FI70415B/fi
Application granted granted Critical
Publication of FI70415C publication Critical patent/FI70415C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/675—Beta-endorphins
    • C07K14/6755—Beta-endorphins with at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C07K14/702—Enkephalins with at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI783589A 1977-11-24 1978-11-23 Foerfarande foer framstaellning av terapeutiskt anvaendbara petider FI70415C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB4898077 1977-11-24
GB48980/77A GB1604850A (en) 1977-11-24 1977-11-24 Biologically active peptides

Publications (3)

Publication Number Publication Date
FI783589A FI783589A (fi) 1979-05-25
FI70415B FI70415B (fi) 1986-03-27
FI70415C true FI70415C (fi) 1986-09-19

Family

ID=10450679

Family Applications (1)

Application Number Title Priority Date Filing Date
FI783589A FI70415C (fi) 1977-11-24 1978-11-23 Foerfarande foer framstaellning av terapeutiskt anvaendbara petider

Country Status (20)

Country Link
US (5) US4244944A (ko)
EP (1) EP0002236B1 (ko)
JP (1) JPS5492938A (ko)
KR (3) KR860000453B1 (ko)
AT (1) AT386211B (ko)
AU (1) AU530985B2 (ko)
CA (1) CA1197235A (ko)
DE (1) DE2862477D1 (ko)
DK (1) DK149612C (ko)
ES (1) ES475324A1 (ko)
FI (1) FI70415C (ko)
GB (1) GB1604850A (ko)
HU (1) HU186729B (ko)
IE (1) IE47517B1 (ko)
IL (1) IL56028A (ko)
IT (1) IT1106143B (ko)
MY (1) MY8500260A (ko)
PL (1) PL123797B1 (ko)
SU (1) SU1470199A3 (ko)
ZA (1) ZA786598B (ko)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK28377A (da) 1976-02-02 1977-08-03 Sandoz Ag Fremgangsmade til fremstilling af polypeptidderivater
GB1604850A (en) * 1977-11-24 1981-12-16 Wellcome Found Biologically active peptides
DE3163199D1 (en) * 1980-07-17 1984-05-24 Sandoz Ag Novel pentapeptides, processes for their production, pharmaceutical compositions comprising said pentapeptides and their use
ATE16495T1 (de) * 1981-06-22 1985-11-15 Ici Plc Peptide und pseudopeptide, die zwei substituenten am n-terminus aufweisen.
US4380535A (en) * 1981-09-23 1983-04-19 American Home Products Corporation Enkephalin degrading enzyme inhibitors
US4492779A (en) * 1981-12-07 1985-01-08 Thiokol Corporation Aramid polymer and powder filler reinforced elastomeric composition for use as a rocket motor insulation
AU566643B2 (en) * 1982-02-05 1987-10-29 Wellcome Foundation Limited, The Pentapeptides as analgesics
DE3378121D1 (de) * 1982-10-18 1988-11-03 Ici Plc Peptide and pseudopeptide derivatives
JPH0680079B2 (ja) * 1984-11-09 1994-10-12 エーザイ株式会社 ポリペプチド
GB8608818D0 (en) * 1986-04-11 1986-05-14 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
GB8616741D0 (en) * 1986-07-09 1986-08-13 Wellcome Found Pharmacologically active compounds
US5688519A (en) * 1987-04-06 1997-11-18 Leonard; Robert J. Flash-flow fused medicinal implants
US5156787A (en) * 1991-01-29 1992-10-20 Booher Benjamin V Pultrusion method of making brake linings
USRE37548E1 (en) 1991-08-12 2002-02-19 Bill J. Hays Clutch design and manufacture
US5482772A (en) 1992-12-28 1996-01-09 Kimberly-Clark Corporation Polymeric strands including a propylene polymer composition and nonwoven fabric and articles made therewith
US6488649B1 (en) 1998-11-24 2002-12-03 Edward M. Lichten Implant device
IL165365A0 (en) 2004-11-24 2006-01-15 Q Core Ltd Finger-type peristaltic pump
KR20080110841A (ko) * 2006-04-21 2008-12-19 루크 라멜렌 운트 쿠프룽스바우 베타일리궁스 카게 다층, 특히 2층 클러치 라이닝 및 그 제조 방법
US8005603B2 (en) 2007-09-27 2011-08-23 Continental Controls Corporation Fuel control system and method for gas engines

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1577115A (en) * 1976-07-27 1980-10-22 Reckitt & Colmann Prod Ltd Container closure units
NZ183712A (en) * 1976-04-08 1979-10-25 Ici Ltd Polypeptide analogues of enkephalins, and pharmaceutical compositions
US4028319A (en) * 1976-05-07 1977-06-07 G. D. Searle & Co. 2 and 3-substituted enkephalins
US4123523A (en) * 1976-06-21 1978-10-31 Imperial Chemical Industries Limited Analgesic and sedative polypeptides
FR2359817A1 (fr) * 1976-07-27 1978-02-24 Reckitt & Colmann Prod Ltd Nouveaux peptides, leur procede de preparation et composition therapeutique les contenant
US4092304A (en) * 1976-08-09 1978-05-30 G. D. Searle & Co. 4-Substituted enkephalin derivatives
PT66982B (en) * 1976-09-01 1979-02-13 Coy David Howard Process for preparing novel methionine enkephalin derivatives
HU178001B (en) * 1976-09-16 1982-02-28 Gyogyszekutato Intezet Process for preparing new pentapeptides with morphine-like activity and derivatives thereof
US4128541A (en) * 1976-12-27 1978-12-05 American Home Products Corporation Pentapeptide with morphine- like activity
DE2819277A1 (de) * 1977-05-16 1978-11-23 Sandoz Ag Neue polypeptidderivate, ihre herstellung und verwendung
US4127523A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel undecapeptides, intermediates therefor, and compositions and methods employing said undecapeptides
US4127532A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel heptapeptides, intermediates therefor, and compositions and methods employing said heptapeptides
US4127531A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel hexapeptides, intermediates therefor, and compositions and methods employing said hexapeptides
US4127533A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel octapeptides, intermediates therefor, and compositions and methods employing said octapeptides
GB1604850A (en) * 1977-11-24 1981-12-16 Wellcome Found Biologically active peptides
US4103005A (en) * 1977-10-20 1978-07-25 Hoffmann-La Roche Inc. Novel-enkephalin analogs

Also Published As

Publication number Publication date
CA1197235A (en) 1985-11-26
AU4186578A (en) 1979-05-31
FI70415B (fi) 1986-03-27
US4362717A (en) 1982-12-07
US4363800A (en) 1982-12-14
DK149612C (da) 1987-01-26
SU1470199A3 (ru) 1989-03-30
US4343795A (en) 1982-08-10
KR830000683A (ko) 1983-04-18
DK523078A (da) 1979-05-25
HU186729B (en) 1985-09-30
IT7852041A0 (it) 1978-11-23
DK149612B (da) 1986-08-11
JPS6318600B2 (ko) 1988-04-19
GB1604850A (en) 1981-12-16
IL56028A (en) 1984-03-30
IL56028A0 (en) 1979-01-31
ZA786598B (en) 1980-06-25
KR880002609B1 (ko) 1988-12-04
PL123797B1 (en) 1982-11-30
JPS5492938A (en) 1979-07-23
KR880002608B1 (ko) 1988-12-04
FI783589A (fi) 1979-05-25
EP0002236B1 (en) 1986-02-05
IE782317L (en) 1979-05-24
EP0002236A1 (en) 1979-06-13
PL211164A1 (pl) 1979-12-17
KR860000453B1 (ko) 1986-04-26
IT1106143B (it) 1985-11-11
AU530985B2 (en) 1983-08-04
MY8500260A (en) 1985-12-31
US4244944A (en) 1981-01-13
IE47517B1 (en) 1984-04-04
KR830000215A (ko) 1983-03-30
AT386211B (de) 1988-07-25
ATA836278A (de) 1987-12-15
KR830000214A (ko) 1983-03-30
US4346083A (en) 1982-08-24
DE2862477D1 (en) 1986-03-20
ES475324A1 (es) 1979-12-01

Similar Documents

Publication Publication Date Title
FI70415C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara petider
KR101021632B1 (ko) 성기능 장애 치료용 조성물 및 치료 방법
DE69427650T2 (de) Verbindungen mit wachstumshormon-freisetzenden eigenschaften
AU711104B2 (en) Compounds with growth hormone releasing properties
JP2001502296A (ja) ニューロペプチド―ｙリガンド
CH644352A5 (en) Process for the preparation of peptides
CA1251898A (en) Pharmaceutical peptides, their preparation and use
US4254106A (en) Biologically active amides
KR100609255B1 (ko) 치환된 1,3-디아릴-2-피리딘-2-일-3-(피리딘-2-일아미노)-프로판올 유도체 및 이를 포함하는 약제학적 조성물
HU199879B (en) Process for producing hexapeptides and pharmaceutical compositions comprising same as active ingredient
US4244945A (en) Biologically active substance
CA2388315A1 (en) Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them
EP0683792A1 (en) Lhrh antagonists having modified aminoacyl residues at postions 5 and 6
EP0000559B1 (en) Pentapeptide-n-alkylamides and their acid addition salts, methods for preparation of these compounds and pharmaceutical formulations containing them
JPH04312599A (ja) ポリペプチド骨格筋弛緩薬
FI64798B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara polypeptider
JPH0570420A (ja) ペプチドアミド及びアミド二量体
GB1596535A (en) Biologically-active peptides
DE2752341A1 (de) Biologisch wirksame amide, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische formulierungen
MXPA97010377A (en) Compounds with releasing properties of growth hormone

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: THE WELLCOME FOUNDATION LIMITED